Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.
about
Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathwayGlobular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.Adiponectin reduces carotid atherosclerotic plaque formation in ApoE-/- mice: roles of oxidative and nitrosative stress and inducible nitric oxide synthase.Acute adiponectin delivery is cardioprotective in the aged female rat heartSystemic adiponectin malfunction as a risk factor for cardiovascular diseaseReduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.Adiponectin at Physiologically Relevant Concentrations Enhances the Vasorelaxative Effect of Acetylcholine via Cav-1/AdipoR-1 SignalingDaming capsule restores endothelial dysfunction induced by high-fat dietHigh glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation.Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview.Role of adiponectin in metabolic and cardiovascular disease.Molecular Cloning and Expression of Osmotin in a Baculovirus-Insect System: Purified Osmotin Mitigates Amyloid-beta Deposition in Neuronal Cells.Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients.Adiponectin-Resistance in Obesity.The triterpenoid alpha, beta-amyrin prevents the impaired aortic vascular reactivity in high-fat diet-induced obese mice.
P2860
Q28574928-B5190C39-2647-48B4-BB44-D5ACCB4678D8Q30279123-798D593B-E10D-47FF-AC3C-F12687DE7AB7Q34731260-7A68CBDF-F7FE-4086-8AA9-4CFC6B32AAC5Q35079725-C3345BA2-830E-4378-ADB8-B4E843ABAF57Q35173604-EC56F281-C086-4056-9062-629C4E1F00E8Q35173617-EF15D456-F953-4730-924E-3EF5E0077971Q35972970-365065F1-40D4-48A0-ABA8-C3C069780E3BQ36059383-DEA750E5-B2C4-4948-A8EB-87C095087E2EQ36386345-EC317D45-561F-4D09-BD7B-A31DE5F97D40Q36510256-8708070A-260E-44E8-8F59-1345AF00085BQ38137028-1511298D-E457-4868-96BB-7C6870F0989FQ38216032-D61ACC93-9D84-4F1F-A187-E43C18234818Q38694836-EE632CC6-E00C-405C-A23A-4CC7E0A014FDQ43504116-023557E6-D026-4FB9-A5CC-7D1D05336430Q50957771-F335E091-4BAD-4D28-B9D6-F846E45AB46FQ54355039-A93098B6-F543-49C6-BBEC-7285F964B66B
P2860
Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reduced vascular responsivenes ...... --mechanisms and significance.
@ast
Reduced vascular responsivenes ...... --mechanisms and significance.
@en
type
label
Reduced vascular responsivenes ...... --mechanisms and significance.
@ast
Reduced vascular responsivenes ...... --mechanisms and significance.
@en
prefLabel
Reduced vascular responsivenes ...... --mechanisms and significance.
@ast
Reduced vascular responsivenes ...... --mechanisms and significance.
@en
P2093
P2860
P1476
Reduced vascular responsivenes ...... --mechanisms and significance.
@en
P2093
Bernard L Lopez
Theodore A Christopher
Wayne Bond Lau
Xiao-Ming Wang
Xiaoliang Wang
Xin-Liang Ma
Xuefeng Wei
P2860
P304
P356
10.1016/J.YJMCC.2010.03.002
P577
2010-03-18T00:00:00Z